Skip to main content
Thorax logoLink to Thorax
. 2000 Sep;55(9):795–797. doi: 10.1136/thorax.55.9.795

Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease

S Thomas 1, A Ray 1, M Hodson 1, T Pitt 1
PMCID: PMC1745865  PMID: 10950901

Abstract

BACKGROUNDPseudomonas aeruginosa may undergo a phenotypic change from the wild (prototrophic) type to an auxotrophic phenotype in the course of respiratory infection in patients with cystic fibrosis. The clinical significance of this is unclear. A study was undertaken to investigate whether the presence of auxotrophs of P aeruginosa in the sputum of patients with cystic fibrosis correlated with severity of respiratory disease, and whether increased sputum concentrations of amino acids were associated with the emergence of these forms.
METHODS—Sixty adult patients with cystic fibrosis, colonised by P aeruginosa, were recruited and baseline clinical data including lung function were recorded. Serial sputum samples were obtained before, during, and after infective exacerbations where possible. These samples were used for routine microbiological culture, assessment of auxotrophy of P aeruginosa, measurement of amino acid content, and neutrophil elastase assay.
RESULTS—Auxotrophy was common in patients with cystic fibrosis and 20 (33%) had a mean percentage auxotroph count of more than 50% total cfu/ml. The mean percentage auxotroph count was inversely correlated with forced expiratory volume in one second (FEV1; τ = -0.194, p = 0.031). The median sputum amino acid concentration of the group was 12.5 mmol/l (range 0.13-40.6). The mean amino acid concentration in 33 subjects during infective exacerbations was 18.2 mmol/l (95% CI 15.1 to 21.3) compared with 12.3 mmol/l (95% CI 9.8 to 14.8) when well (p = 0.001). The amino acid content of sputum was inversely correlated with FEV1 (τ = -0.253, p =0.005).
CONCLUSIONSP aeruginosa frequently exhibits auxotrophy in patients with cystic fibrosis, particularly in those with severe underlying pulmonary disease. The sputum amino acid content of patients with cystic fibrosis is high during infective exacerbations and correlates with pulmonary disease severity.



Full Text

The Full Text of this article is available as a PDF (120.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barth A. L., Pitt T. L. Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol. 1995 Jan;33(1):37–40. doi: 10.1128/jcm.33.1.37-40.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barth A. L., Pitt T. L. The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol. 1996 Aug;45(2):110–119. doi: 10.1099/00222615-45-2-110. [DOI] [PubMed] [Google Scholar]
  3. Kelly-Wintenberg K., Montie T. C. Chemotaxis to oligopeptides by Pseudomonas aeruginosa. Appl Environ Microbiol. 1994 Jan;60(1):363–367. doi: 10.1128/aem.60.1.363-367.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Pamukcu A., Bush A., Buchdahl R. Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol. 1995 Jan;19(1):10–15. doi: 10.1002/ppul.1950190103. [DOI] [PubMed] [Google Scholar]
  5. Pouw E. M., Schols A. M., Deutz N. E., Wouters E. F. Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Sep;158(3):797–801. doi: 10.1164/ajrccm.158.3.9708097. [DOI] [PubMed] [Google Scholar]
  6. Quanjer P. H., Tammeling G. J., Cotes J. E., Pedersen O. F., Peslin R., Yernault J. C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993 Mar;16:5–40. [PubMed] [Google Scholar]
  7. Rosenthal M., Bain S. H., Cramer D., Helms P., Denison D., Bush A., Warner J. O. Lung function in white children aged 4 to 19 years: I--Spirometry. Thorax. 1993 Aug;48(8):794–802. doi: 10.1136/thx.48.8.794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Taylor R. F., Hodson M. E., Pitt T. L. Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa. Thorax. 1993 Oct;48(10):1002–1005. doi: 10.1136/thx.48.10.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Taylor R. F., Hodson M. E., Pitt T. L. Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis. FEMS Microbiol Lett. 1992 May 1;71(3):243–246. doi: 10.1016/0378-1097(92)90716-2. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES